AU2001268361A1 - Method of modulating expression of ldl-receptor-related protein and uses thereof - Google Patents
Method of modulating expression of ldl-receptor-related protein and uses thereofInfo
- Publication number
- AU2001268361A1 AU2001268361A1 AU2001268361A AU6836101A AU2001268361A1 AU 2001268361 A1 AU2001268361 A1 AU 2001268361A1 AU 2001268361 A AU2001268361 A AU 2001268361A AU 6836101 A AU6836101 A AU 6836101A AU 2001268361 A1 AU2001268361 A1 AU 2001268361A1
- Authority
- AU
- Australia
- Prior art keywords
- ldl
- receptor
- related protein
- modulating expression
- modulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61253300A | 2000-07-07 | 2000-07-07 | |
| US09612533 | 2000-07-07 | ||
| PCT/US2001/018919 WO2002003985A1 (en) | 2000-07-07 | 2001-06-13 | Method of modulating expression of ldl-receptor-related protein and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001268361A1 true AU2001268361A1 (en) | 2002-01-21 |
Family
ID=24453566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001268361A Abandoned AU2001268361A1 (en) | 2000-07-07 | 2001-06-13 | Method of modulating expression of ldl-receptor-related protein and uses thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001268361A1 (en) |
| WO (1) | WO2002003985A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10154221A1 (en) * | 2001-11-07 | 2003-05-15 | Max Delbrueck Centrum | Agent for the treatment of lesions of the nervous system |
| US7169559B2 (en) * | 2002-05-13 | 2007-01-30 | Fonterra Corporate Research and Development Ltd. | LDL receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions |
| GB201505305D0 (en) | 2015-03-27 | 2015-05-13 | Immatics Biotechnologies Gmbh | Novel Peptides and combination of peptides for use in immunotherapy against various tumors |
| ES2970246T3 (en) | 2015-03-27 | 2024-05-27 | Immatics Biotechnologies Gmbh | Novel peptides and peptide combination to be used in immunotherapy against different tumors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5776502A (en) * | 1989-07-18 | 1998-07-07 | Oncogene Science, Inc. | Methods of transcriptionally modulating gene expression |
-
2001
- 2001-06-13 AU AU2001268361A patent/AU2001268361A1/en not_active Abandoned
- 2001-06-13 WO PCT/US2001/018919 patent/WO2002003985A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002003985A1 (en) | 2002-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001259215A1 (en) | Human anti-cd40 antibodies and methods of making and using same | |
| AU2002230831A1 (en) | Compositions of human proteins and method of use thereof | |
| AU2001277172A1 (en) | Bstp-trans protein and related reagents and methods of use thereof | |
| HK1205183A1 (en) | High mannose proteins and methods of making high mannose proteins | |
| AU2002211389A1 (en) | Microfluidic devices and methods of use | |
| AU2001270943A1 (en) | Surgical instrument and method of using the same | |
| AU2001251358A1 (en) | Prion-binding ligands and methods of using same | |
| AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
| AU2000278326A1 (en) | Interactive and animated mini-theater and method of use | |
| HK1053673A1 (en) | Methods of protein destabilization and uses thereof | |
| AU2001296581A1 (en) | Micromachined component and method of manufacture | |
| AU2001247600A1 (en) | Methods of modulating hair growth | |
| AU2001278011A1 (en) | Bstp-ecg1 protein and related reagents and methods of use thereof | |
| AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
| AU2001272027A1 (en) | Artificial nail and method for applying same | |
| AU2002322887A1 (en) | Peptide sequence tags and method of using same | |
| AU2002224404A1 (en) | Container and method of sealing | |
| AU2002363938A1 (en) | Methods and use of motoneuronotropic factors | |
| AU2001261375A1 (en) | Human caspase-12 materials and methods | |
| AU2002364612A1 (en) | METHODS AND MATERIALS FOR MODULATING ENaC-BETA | |
| AU2001268361A1 (en) | Method of modulating expression of ldl-receptor-related protein and uses thereof | |
| AU2001278899A1 (en) | Chiral integrin modulators and methods of use thereof | |
| AU2001249692A1 (en) | Phospholipid scramblases and methods of use thereof | |
| AU2001261496A1 (en) | Luxo-sigma54 interactions and methods of use | |
| AU2001284651A1 (en) | Secreted proteins and methods of using same |